Uggeri, Matteo

Uggeri, Matteo  

Dipartimento di Medicina Molecolare e Traslazionale  

Mostra records
Risultati 1 - 17 di 17 (tempo di esecuzione: 0.025 secondi).
Titolo Data di pubblicazione Autore(i) File
A broad-spectrum anti-angiogenic tetrapeptide regresses diabetic retinopathy through β-arrestin-1 binding and prevention of Akt phosphorylation 1-gen-2025 Zani, A.; Bugatti, A.; Maceroni, E.; Duheric, M.; Uggeri, M.; Manocha, E.; Bertelli, M.; D'Angelo, M.; Cimini, A.; Caccuri, F.; Caruso, A.
AN ANTIVIRAL STRATEGY AGAINST SARS-CoV-2 SPIKE PROTEIN BASED ON REDUCING AGENTS 1-gen-2022 Uggeri, Matteo; Milanesi, M.; Biasin, M.; Strizzi, M.; Bernardo, S.; De Palma, L.; Mauri, A.; Manconi, P.; Orro, A.; Urbinati, A.; Rusnati, C.; D’Ursi, M.; and Fossa, P.
Computational evaluation of the synergic effect of a small molecule on Lumacaftor F508del-CFTR rescue ability 1-gen-2021 Uggeri, M.; Orro, A.; Urbinati, C.; Rusnati, M.; Fossa P., and D’Ursi P
Detection of HIV-1 matrix protein p17 in sera of viremic and aviremic patients 1-gen-2024 Zani, A.; Messali, S.; Uggeri, M.; Bonfanti, C.; Caruso, A.; Caccuri, F.
DOES NICOTINAMIDE COMBINES WITH LUMACAFTOR TO IMPROVE F508del-CFTR RESCUE? 1-gen-2021 Uggeri, M.; Orro, A.; Urbinati, C.; Rondina, A.; Milanesi, M.; Rusnati, M.; D’Ursi, P.; Fossa, P.
heparin and heparan sulfate proteoglycans promotes hiv-1 p17 matrix protein oligomerization: computational, biochemical and biological implications 1-gen-2019 Paiardi, G.; Bugatti, A.; Urbinati, C.; Chiodelli, P.; Orro, A.; Uggeri, M.; Caruso, A.; Caccuri, F.; D'Ursi, P.; Rusnati, M.
implementation of a new computational protocol based on incremental docking to study interaction of long sugar chain with proteins: heparin/HIV-1 p17 case study 1-gen-2019 Paiardi, G.; Urbinati, C.; Chiodelli, P.; Orro, A.; Uggeri, M.; Milanesi, L.; D'Ursi, P.; Rusnati, M.
implementation of an incremental docking method to study long sugar chains interactions with proteins 1-gen-2019 Paiardi, G.; Urbinati, C.; Chiodelli, P.; Orro, A.; Uggeri, M.; Milanesi, L.; Rusnati, M.; D'Ursi, P.
Molecular mechanisms behind the generation of pro-oncogenic HIV-1 matrix protein p17 variants 1-gen-2024 Zani, Alberto; Messali, Serena; Bugatti, Antonella; Uggeri, Matteo; Rondina, Alessandro; Sclavi, Leonardo; Caccuri, Francesca; Caruso, Arnaldo
Molecular Mechanisms Involved in the B Cell Growth and Clonogenic Activity of HIV-1 Matrix Protein p17 Variants 1-gen-2024 D'Ursi, Pasqualina; Rondina, Alessandro; Zani, Alberto; Uggeri, Matteo; Messali, Serena; Caruso, Arnaldo; Caccuri, Francesca
multidisciplinary approaches to rescue CFTR impairments by drug repositioning 1-gen-2019 Uggeri, M.; Orro, A.; Urbinati, C.; Millo, E.; Paiardi, G.; Milanesi, L.; Pedemonte, N.; Fossa, P.; Rusnati, M.; D'Ursi, P.
rescuing defective CFTR applying a drug repositioning strategy 1-gen-2019 Uggeri, M.; Orro, A.; Millo, E.; Cichero, E.; Paiardi, G.; Milanesi, L.; Pedemonte, N.; Rusnati, M.; D'Ursi, P.; Fossa, P.
rescuing defective CFTR applying a drug repositioning strategy based on computational studies, surface plasmon resonance and cell based assays 1-gen-2020 Fossa, P.; Orro, A.; Urbinati, C.; Uggeri, M.; Rondina, A.; Nale, V.; Milanesi, M.; Pedemonte, N.; D'Ursi, P.; Rusnati, M.
rescuing defective CFTR applying a drug repositioning strategy based on computational studies, surface plasmon resonance and cell based assays 1-gen-2018 D'Ursi, P.; Orro, A.; Urbinati, C.; Uggeri, M.; Paiardi, G.; Millo, E.; Milanesi, L.; Fossa, P.; Rusnati, M.
rescuing defective CFTR applying a drug repositioning strategy based on computational studies, surface plasmon resonance and cell based assays 1-gen-2019 D'Ursi, P.; Orro, A.; Urbinati, C.; Uggeri, M.; Paiardi, G.; Millo, E.; Milanesi, L.; Pedemonte, N.; Fossa, P.; Rusnati, M.
The Tumor Cell Proliferation Inhibitory Activity of the Human Herpes Virus Type 6 U94 Protein Relies on a Stable Tridimensional Conformation 1-gen-2026 Bertelli, Anna; Uggeri, Matteo; Filippini, Federica; Duheric, Melissa; Caccuri, Francesca; Caruso, Arnaldo
UV-C EXPOSURE SUGGESTS A SARS-CoV-2 SPIKE PROTEIN ANTIVIRAL STRATEGY BASED ON REDUCING AGENTS 1-gen-2022 Milanesi, M(; Clerici, M; Mauri, P; Manconi, A; Uggeri, M; Fossa, P; Urbinati, C; Rusnati, M and D’Ursi P